Drug intelligence / Profile preview

Azéane

Development stage
Unknown
Lead developer
Laboratoire Dermatologique ACM
Modality
Small Molecules
Administration
Topical
01

Overview

Azéane is a topical dermatological cream containing 15% azelaic acid, developed by Laboratoire ACM for the management of skin imperfections associated with acne and rosacea. Azelaic acid is a naturally occurring dicarboxylic acid that provides a multi-modal therapeutic approach. It acts as an antibacterial agent by inhibiting the protein synthesis of *Cutibacterium acnes* and *Staphylococcus epidermidis*. As a keratolytic agent, it normalizes the keratinization process, thereby reducing the formation of comedones. In the context of rosacea, azelaic acid exerts anti-inflammatory effects by downregulating the expression of pro-inflammatory mediators such as kallikrein-5 and cathelicidin, and by scavenging reactive oxygen species. Additionally, it is a competitive inhibitor of tyrosinase, which helps in reducing post-inflammatory hyperpigmentation and melasma.

Brand names
Azéane
Other names
Azéane Crème
02

Targets

CAMP (Cathelicidin antimicrobial peptide)TLR2 (Toll-like Receptor 2)KLK5 (Kallikrein-related peptidase 5)TYR (Tyrosinase)

Beyond the preview

Go deeper on Azéane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azéane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call